Organon Return on Tangible Equity 2019-2025 | OGN
Current and historical return on tangible equity values for Organon (OGN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Organon Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-12-31 | $0.86B | $-5.62B | -16.53% |
| 2024-09-30 | $1.30B | $-4.87B | -25.39% |
| 2024-06-30 | $1.00B | $-5.14B | -18.71% |
| 2024-03-31 | $1.05B | $-5.27B | -19.05% |
| 2023-12-31 | $1.02B | $-5.21B | -18.05% |
| 2023-09-30 | $0.59B | $-5.75B | -9.91% |
| 2023-06-30 | $0.75B | $-5.75B | -12.47% |
| 2023-03-31 | $0.75B | $-5.96B | -12.02% |
| 2022-12-31 | $0.92B | $-6.14B | -14.45% |
| 2022-09-30 | $1.01B | $-6.34B | -15.56% |
| 2022-06-30 | $1.11B | $-6.38B | -16.67% |
| 2022-03-31 | $1.30B | $-6.52B | -18.96% |
| 2021-12-31 | $1.35B | $-6.76B | -25.40% |
| 2021-09-30 | $1.52B | $-6.90B | -42.93% |
| 2021-06-30 | $1.74B | $-7.25B | -96.31% |
| 2021-03-31 | $1.86B | $-0.36B | 43670.59% |
| 2020-12-31 | $2.16B | $0.38B | 2273.68% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.457B | $6.403B |
| Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. | |||